# BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
> **ANDA215995** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2022-01-26
## Drug
- **FDA Application Number:** ANDA215995
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
- **Generic name:** BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
- **Active ingredients:** BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GLENMARK PHARMS LTD
- **Manufacturer:** GLENMARK PHARMACEUTICALS INC., USA
- **First approval:** 2022-01-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215995)
---
*AI Analytics · CC0 1.0*